Recent News for UROV - Urovant Sciences Ltd.

Date Title
Aug 14 Urovant Sciences Limited (UROV) CEO Keith Katkin on Q1 2019 Results - Earnings Call Transcript
Aug 14 Urovant Sciences Ltd (UROV) Q1 2019 Earnings Call Transcript
Aug 13 Urovant Sciences EPS beats by $0.02
Aug 13 Urovant Sciences Reports 2019 First Fiscal Quarter Financial Results
Aug 13 The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results
Aug 13 Earnings Scheduled For August 13, 2019
Aug 11 The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO
Aug 6 Urovant Sciences to Report 2019 First Fiscal Quarter Financial Results
Jun 29 Here’s What Hedge Funds Think About Urovant Sciences Ltd. (UROV)
Jun 20 Urovant Sciences Ltd. (NASDAQ:UROV): Immense Growth Potential?
Jun 14 The Daily Biotech Pulse: Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA
Jun 14 Urovant Sciences Limited (UROV) CEO Keith Katkin on Q4 2018 Results - Earnings Call Transcript
Jun 13 Urovant Sciences EPS misses by $0.01
Jun 13 Urovant Sciences Reports Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
Jun 13 Urovant Sciences Ltd. to Host Earnings Call
Jun 13 Earnings Scheduled For June 13, 2019
Jun 6 Urovant Sciences to Report Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
Jun 3 Urovant Sciences to Present at Annual Roivant Pipeline Day
May 30 Urovant Sciences to Present at the Jefferies 2019 Healthcare Conference
May 6 Urovant up 5% on successful late-stage vibegron studies
May 6 Urovant Sciences Presents Positive Pivotal Data for Vibegron During Plenary Session at American Urological Association Annual Meeting
Apr 29 Urovant Sciences to Present Late-Breaking Data on Vibegron During Plenary Session at the American Urological Association Annual Meeting
Mar 28 Evolus And Urovant: Similar Strategies, Opposite Reactions To Positive Catalysts
Mar 27 Urovant Sciences Initiates Phase 3 Clinical Program with Vibegron for Overactive Bladder in Men with Benign Prostatic Hyperplasia
Mar 19 Here's Why Urovant Sciences Got Whacked on "Positive" Clinical Trial Data
Back to the Main UROV Page...